Petra Ovesná
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Hemophilia Treatment and Research
Papers in
- Genetics 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Hematology 17
- Hemophilia Treatment and Research 9
- Platelet Disorders and Treatments 8
- Co-authors
- Alois Kozubı́kVı́tězslav BryjaMiroslav PenkaPavlína JanovskáŠárka Pospı́šilováKarla PlevováŠárka PavlováM. Bláha
- Journals
- Blood Coagulation & Fibrinolysis (3 papers)Thrombosis Research (3 papers)Blood (2 papers)International Journal of Molecular Sciences (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- CzechiaUnited KingdomUnited States
In The Last Decade
Petra Ovesná
66 papers receiving 822 citations
Peers
Comparison fields: 5 of 101
- Genetics 154
- Hematology 133
- Reproductive Medicine 59
- Obstetrics and Gynecology 52
- Cancer Research 88
Countries citing papers authored by Petra Ovesná
This map shows the geographic impact of Petra Ovesná's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Ovesná with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Ovesná more than expected).
Fields of papers citing papers by Petra Ovesná
This network shows the impact of papers produced by Petra Ovesná. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Ovesná. The network helps show where Petra Ovesná may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Ovesná, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 0 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 30 | |
| 13 | 2019 | 13 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 52 | |
| 17 | 2013 | 82 | |
| 18 | [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]. | 2013 | 0 |
| 19 | 2012 | 9 | |
| 20 | [Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic]. | 2010 | 0 |
About Petra Ovesná
Petra Ovesná is a scholar working on Genetics, Hematology, Reproductive Medicine, Obstetrics and Gynecology and Health Informatics, having authored 77 papers that have together received 838 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Ovarian cancer diagnosis and treatment (10 papers), Hemophilia Treatment and Research (9 papers), Endometrial and Cervical Cancer Treatments (9 papers), Platelet Disorders and Treatments (8 papers), Eosinophilic Disorders and Syndromes (7 papers), Kruppel-like factors research (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). The work is most often cited by research in Genetics (154 citations), Hematology (133 citations), Reproductive Medicine (59 citations), Obstetrics and Gynecology (52 citations) and Cancer Research (88 citations). Petra Ovesná has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Alois Kozubı́k, Vı́tězslav Bryja, Miroslav Penka, Pavlína Janovská, Šárka Pospı́šilová, Karla Plevová, Šárka Pavlová, M. Bláha, Jiřina Hofmanová and Michael Doubek. Their work appears in journals such as Blood Coagulation & Fibrinolysis, Thrombosis Research, Blood, International Journal of Molecular Sciences and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.